Press Releases

Filters
March 25, 2020

Debiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical’s targeted CAIX radiotherapy

Read more
March 5, 2020

Debiopharm Advances into the Highly Anticipated Clinical Phase for their Potent WEE1 Inhibitor

Read more
February 27, 2020

FDA grants Breakthrough Therapy Designation for Debiopharm’s novel chemo-radio sensitizer Debio 1143 for front-line treatment of Head & Neck Cancer

Read more
February 6, 2020

Challenge pour la Qualité de vie du patient 2020 : l’appel à projets est ouvert

Read more
January 9, 2020

Novadiscovery raises series A financing to scale its in silico clinical trial platform – Debiopharm leads the round with EUR…

Read more
January 8, 2020

Knight Partners with Debiopharm for the Commercialization of Trelstar® in Canada

Read more
November 17, 2019

Grand gagnant du Challenge 2019 pour la qualité de vie du patient, le projet Rise-Up de chaise élévatrice qui aide…

Read more
November 11, 2019

Après-demain Holding SA acquiert une participation dans le réseau de crèches Little Green House (Suisse)

Read more
November 8, 2019

Debiopharm progresses in their stand against drug-resistant N. gonorrhoeae with extended CARB-X funding of their Debio 1453 antibiotic program

Read more